Colombia's drug regulator has authorized emergency use of Pfizer and BioNTech's COVID-19 vaccine, as reported in Fidelity.
The country now awaits approval for vaccines produced by AstraZeneca and Johnson & Johnson, noted President Ivan Duque.
According to the news source, patients aged 60 and over, or with co-morbidities such as asthma and diabetes, will be among the first in line for vaccines, as well as health workers.
Colombia has reached deals to buy 10 million doses each of the Pfizer/BioNTech and AstraZeneca vaccines, as well as 9 million from Johnson & Johnson. The country has also secured 20 million vaccine doses via the World Health Organization-backed COVAX mechanism.
Colombia will receive its first delivery of 1.7 million Pfizer/BioNTech vaccine doses in February, with vaccinations beginning immediately, according to the minister of health.
To read more NewsPoints articles, click here.